Brief: Roche Says Co Commences Tender Offer For All Shares Of 89Bio
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Roche to acquire liver drug developer 89bio for up to $3.5 billion (updated)
Roche to acquire liver drug developer 89bio for up to $3.5 billion
Brief: 89Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
89Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: 89bio Q2 Net Income USD -111.504 Million Vs. IBES Estimate USD -73.5 Million
Brief: 89Bio Announces Inducement Grants Under Nasdaq Listing Rule
U.S. STOCKS ON THE MOVE-MeiraGTx, CervoMed, Natgas companies
U.S. STOCKS ON THE MOVE-Metropolitan Bank, Fossil, MeiraGTx
U.S. STOCKS ON THE MOVE-Xpeng, D-Wave Quantum, Trinity Biotech
Citi initiates coverage on 89bio with 'buy' rating on potential for MASH therapy
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Microsoft
Citi starts coverage on 'insulated' SMid biotechs amid healthcare policy uncertainty
89Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: 89bio Q4 Net Income USD -118.354 Million Vs. IBES Estimate USD -84.1 Million
U.S. STOCKS ON THE MOVE-Signing Day Sports, Merchants Bancorp, Stride